PDGFR
Platelet-derived growth factor receptor
PDGFR Isoform Specific Products
All Product Categories
-
PDGFR Inhibitors
(292)
View all products
-
PDGFR Antagonist
(1)
View all products
-
PDGFR Activators
(3)
View all products
-
PDGFR Modulators
(2)
View all products
-
PDGFR Chemical
(1)
View all products
-
PDGFR Degrader
(1)
View all products
-
PDGFR Control
(1)
View all products
-
PDGFR Ligands
(9)
View all products
-
PDGF-R-alpha Proteins
(12)
View all products
-
PDGF-R-beta Proteins
(8)
View all products
-
PDGFR Proteins
(22)
View all products
-
PDGFR Produits associés (337)
Produits associés (337)
-
Protéines Recombinantes (22)
-
Anticorps (5)
-
PDGFR Isoform Comparison
-
Sorafenib
0 ImagesSynonyms: Bay 43-9006Sorafenib (Bay 43-9006) is a potent oral active multikinase inhibitor. Sorafenib blocks autophosphorylation and activity of receptor tyrosine kinases (VEGFR-2, VEGFR-3) and RAF family kinases, thereby suppressing the RAF/MEK/ERK and PI3K/Akt pathways, inhibiting STAT3 phosphorylation, and selectively inhibiting the MAPK pathway in cancer cells. Sorafenib induces cell cycle arrest, autophagy, apoptosis, and PARP cleavage, reduces Bcl-2, Bcl-XL, cyclin D1 levels, and activates Bak and Bax. Sorafenib inhibits tumor growth and metastasis in mouse and rat models. Sorafenib can be used for cancer research, such as colon, breast, non-small-cell lung cancer (NSCLC), ovarian, pancreatic, melanoma, colorectal and hepatocellular carcinoma. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
Lenvatinib
0 ImagesSynonyms: E7080; MK-7902 -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
Nintedanib
0 ImagesSynonyms: BIBF 1120; IntedanibNintedanib (BIBF 1120; Intedanib) is an orally active receptor tyrosine kinase inhibitor. Nintedanib inhibits FGFR1-3, PDGFRα/β, and VEGFR1-3 through competitive binding to the ATP pocket, and blocks PI3K/Akt/mTOR phosphorylation. Nintedanib exhibits anti-inflammatory, antioxidant, anti-apoptotic, and anti-fibrotic effects, reducing collagen deposition, fibroblast activation, angiogenesis, airway inflammation and hyperresponsiveness, and cytokine/chemokine expression. Nintedanib ameliorates Bleomycin (HY-108345)-induced lung injury and dystrophic muscle pathology; it also delays tumor growth and prolongs survival, and immune checkpoint blockade enhances its antitumor efficacy. Nintedanib can be used in research on pulmonary fibrosis, cancer, systemic sclerosis, chronic asthma, and rheumatoid arthritis-associated interstitial lung disease. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
Imatinib
0 ImagesSynonyms: STI571; CGP-57148BImatinib (STI571) is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity. Imatinib (STI571) works by binding close to the ATP binding site, locking it in a closed or self-inhibited conformation, therefore inhibiting the enzyme activity of the protein semicompetitively. Imatinib also is an inhibitor of SARS-CoV and MERS-CoV. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
Sunitinib
0 ImagesSynonyms: SU 11248Sunitinib (SU 11248) is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ, respectively. Sunitinib, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1α by inhibiting autophosphorylation and consequent RNase activation. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
Regorafenib
0 ImagesSynonyms: BAY 73-4506 -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
- Ponatinib
-
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
- Axitinib
-
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
Quizartinib
0 ImagesSynonyms: AC220Quizartinib (AC220) is an orally active, potent and selective FLT3 inhibitor. Quizartinib inhibits kinase activity of mutant-FLT3, -PDGFRA and -KIT isoforms and inhibits autophosphorylation. Quizartinib inhibits cellular proliferation, induces apoptosis in cancer cells. Quizartinib can be used for the research of cancer. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
- Pazopanib
-
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
Avapritinib
0 ImagesSynonyms: BLU-285Avapritinib (BLU-285) is a highly potent, selective, and orally active KIT and PDGFRA activation loop mutant kinases inhibitor with IC50s of 0.27 and 0.24 nM for KIT D816V and PDGFRA D842V, respectively. Avapritinib (BLU-285) binds the active conformation of the kinase and shows antitumor activity. Avapritinib (BLU-285) attenuates the transport function of both ABCB1 and ABCG2. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
- SU 5402
-
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
Nintedanib esylate
0 ImagesSynonyms: BIBF 1120 esylate; Intedanib esylateNintedanib esylate (BIBF 1120 esylate; Intedanib esylate) is an orally active receptor tyrosine kinase inhibitor. Nintedanib esylate inhibits FGFR1-3, PDGFRα/β, and VEGFR1-3 through competitive binding to the ATP pocket, and blocks PI3K/Akt/mTOR phosphorylation. Nintedanib esylate exhibits anti-inflammatory, antioxidant, anti-apoptotic, and anti-fibrotic effects, reducing collagen deposition, fibroblast activation, angiogenesis, airway inflammation and hyperresponsiveness, and cytokine/chemokine expression. Nintedanib esylate ameliorates Bleomycin (HY-108345)-induced lung injury and dystrophic muscle pathology; it also delays tumor growth and prolongs survival, and immune checkpoint blockade enhances its antitumor efficacy. Nintedanib esylate can be used in research on pulmonary fibrosis, cancer, systemic sclerosis, chronic asthma, and rheumatoid arthritis-associated interstitial lung disease. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
Lenvatinib mesylate
0 ImagesSynonyms: E7080 mesylate; MK-7902 mesylate -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
Luminespib
0 ImagesSynonyms: VER-52296; AUY922; NVP-AUY922Luminespib (VER-52296) is a potent HSP90 inhibitor, with IC50 values of 7.8 nM for HSP90α and 21 nM for HSP90β. By inhibiting HSP90, Luminespib blocks multiple signaling pathways—mediated by EGF, VEGF, and PDGF—that promote cell proliferation, metastasis, and angiogenesis; consequently, it suppresses cancer cell proliferation, migration, and invasion, as well as the formation of new blood vessels. Luminespib can be used in research on cancers such as pancreatic cancer and prostate cancer. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
- CP-673451
-
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
- Imatinib Mesylate
-
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
Crenolanib
0 ImagesSynonyms: CP-868596 -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
Sunitinib Malate
0 ImagesSynonyms: SU 11248 MalateSunitinib (SU 11248) Malat is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ, respectively. Sunitinib Malat, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1α by inhibiting autophosphorylation and consequent RNase activation. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
-
Sorafenib tosylate
0 ImagesSynonyms: Bay 43-9006 tosylateSorafenib (Bay 43-9006) tosylate is a potent oral active multikinase inhibitor. Sorafenib blocks autophosphorylation and activity of receptor tyrosine kinases (VEGFR-2, VEGFR-3) and RAF family kinases, thereby suppressing the RAF/MEK/ERK and PI3K/Akt pathways, inhibiting STAT3 phosphorylation, and selectively inhibiting the MAPK pathway in cancer cells. Sorafenib tosylate induces cell cycle arrest, autophagy, apoptosis, and PARP cleavage, reduces Bcl-2, Bcl-XL, cyclin D1 levels, and activates Bak and Bax. Sorafenib tosylate inhibits tumor growth and metastasis in mouse and rat models. Sorafenib tosylate can be used for cancer research, such as colon, breast, non-small-cell lung cancer (NSCLC), ovarian, pancreatic, melanoma, colorectal and hepatocellular carcinoma. -
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
No matching results
No matching results
No matching results
No matching results
-
loading...Please select quantityObtenir un devis
August 31
-
Please select quantity
August 31
Obtenir un devis
loading... -
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
Your Search Returned No Results.
Sorry. There is currently no product that acts on isoform Bcl-2, Bcl-W and Bim together.Please
try each isoform separately.